about
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature.Eptifibatide-induced acute profound thrombocytopenia presenting as refractory hypotension.Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays.Acquired Glanzmann's thrombasthenia as part of multiple-autoantibody syndrome in a pediatric heart transplant patient.Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug.Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors.Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopeniaVancomycin-induced immune thrombocytopenia.Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B.Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia.Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.Severe autoimmune neutropenia associated with acute autoimmune hepatitis.Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopeniaThe human platelet antigen-21bw is relatively common among Asians and is a potential trigger for neonatal alloimmune thrombocytopenia.Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.Protamine-induced immune thrombocytopenia.Drug-induced thrombocytopenia in children.Human platelet antigens - 2013.Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia.Irinotecan-induced immune thrombocytopenia.A case of oxaliplatin-induced immune-mediated thrombocytopenia.Bortezomib for refractory autoimmunity in pediatrics.Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia.Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms.Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.A new low-frequency alloantigen (Kha(b) ) located on platelet glycoprotein IIIa as a cause of maternal sensitization leading to neonatal alloimmune thrombocytopenia.Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH.Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.Immune thrombocytopenia due to Trimethoprim-Sulfamethoxazole; under-recognized adverse drug reaction in children?A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HITRecent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia.CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypesA Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.Severe neonatal alloimmune thrombocytopenia caused by maternal sensitization against a new low-frequency alloantigen (Domb ) located on platelet glycoprotein IIIa.
P50
Q33343982-84A09F17-5086-4665-B28F-517667951F62Q33345265-220AC763-08C0-4463-AB82-5EF4B0C0CF64Q33345911-89063AD8-83CE-42E8-AD3C-68EF6FB58D47Q33356915-15994373-8302-4789-92D3-E9EC075D32F1Q33360678-E463973F-7368-4D87-BAA6-C1F78B984BDFQ33360759-8E00CB16-D0A9-41B9-9277-65A944F85D7AQ33360832-BF769EDC-F8DE-4A89-A859-EE0C4E8AB1ECQ33363382-D8AAE78F-4767-4AD9-A0E7-37AAA604689DQ33368179-80EA58D1-F01B-4DF4-A555-EFF1D71E68CEQ33374388-D735F87A-AF91-430A-9EB5-6EE7CCE331FEQ33377497-4366B71F-E320-47AA-BFC7-DF80E69578CFQ33386494-F0A76E1C-A553-497B-81DC-6702BA6C3CC8Q33386599-9CA49EEE-FE11-4CCB-B628-D55802A842EEQ33388956-7162405C-C370-40C9-8C71-A12CB6D65A19Q33389008-FE49433C-61C3-4E57-8BCA-695620F32CDCQ33389987-8E125D1C-3D0B-4DCD-B134-9EC47E3A8ACAQ33398132-3628A798-28C6-44F0-88A7-C126936797E9Q33400663-F59AF09A-9450-48A5-B323-0E7ED1B4AC4CQ33401466-DEB17D7C-F252-4C9D-847D-0B6BD20D2C31Q33403500-1F512CC1-AC7C-4F60-92C5-A510815DB312Q33405699-D9B5AC78-EED9-46FA-A9A0-0D786E3D156AQ33410359-37F9C263-F4F7-4947-B3C3-B180F7383E1AQ33410804-BA4F35AE-A214-4BC8-BE86-52B6C470BE8BQ33410953-07297F65-07FB-46F5-95D5-F5C6FB1DF27FQ33412997-9DFBD69F-B125-4002-A6B1-1A804B77952EQ33414565-0F68CA53-CEBA-41A0-A94B-63535DBDEB60Q33416187-1E99818E-8D79-49B6-93F6-C4190D717CD6Q33416698-8338CC4E-1308-4715-8AC2-CE4585C24622Q33417800-70588170-8B86-45B8-A074-F5EE80F52C82Q33418371-3E6733C3-B508-4375-ADD9-CD811DBD7D96Q33419255-8FB62B50-DAF0-4B25-84F4-0F30B44AAF82Q33419883-AA08CEC5-F3B1-4CF7-B008-CA7796C6046EQ33420100-1E8494CB-40BC-44D6-B108-E376C35CDA5DQ33420453-B123E2DE-2378-4716-81F6-E587DF3433B5Q33424447-0A4A5FA8-414F-481A-87EF-03E36CAE03F5Q33425658-EA260DEB-EF5C-4CDD-BE9D-70D2010AD331Q33428137-5D3484F2-3F38-43E8-B1F3-3BD51B92536DQ33430223-DD7BFA4C-84F0-484E-93AC-0B72E61D6376Q33441202-73697F0A-06F1-441B-B6E5-8DEFB5B3A0A5Q33441960-1373CF95-B46B-4B4E-9996-CE5F94B20B90
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
B R Curtis
@ast
B R Curtis
@es
Brian Curtis
@en
Brian Curtis
@nl
Brian Curtis
@pl
type
label
B R Curtis
@ast
B R Curtis
@es
Brian Curtis
@en
Brian Curtis
@nl
Brian Curtis
@pl
altLabel
B R Curtis
@en
prefLabel
B R Curtis
@ast
B R Curtis
@es
Brian Curtis
@en
Brian Curtis
@nl
Brian Curtis
@pl
P31
P496
0000-0001-9553-9081